Literature DB >> 28927176

Permanent work disability in patients ≤50 years old after percutaneous coronary intervention and coronary artery bypass grafting (the CRAGS study).

Anna Lautamäki1, Jarmo M Gunn1, Kari Eino Juhani Airaksinen1, Fausto Biancari2, Olli A Kajander3, Vesa Anttila2, Jouni Heikkinen2, Markku Eskola3, Erkki Ilveskoski3, Ari Mennander3, Kari Korpilahti4, Jan-Ola Wistbacka4, Tuomas O Kiviniemi1.   

Abstract

Background: The aim of this study was to investigate the incidence of permanent working disability (PWD) in young patients after percutaneous or surgical coronary revascularization. Methods and
Results: The study included 1035 consecutive patients ≤50 years old who underwent coronary revascularization [910 and 125 patients in percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) groups, respectively] between 2002 and 2012 at 4 Finnish hospitals. The median follow-up time was 41 months. The overall incidence of PWD was higher after CABG compared to PCI (at 5 years, 34.8 vs. 14.7%, P < 0.001). Freedom from PWD in the general population aged 45 was 97.2% at 4 years follow-up. Median time to grant disability pension was 11.6 months after CABG and 24.4 months after PCI (P = 0.018). Reasons for PWD were classified as cardiac (35.3 vs. 36.9%), psychiatric (14.7 vs. 14.6%), and musculoskeletal (14.7 vs. 15.5%) in patients undergoing CABG vs. PCI. Overall freedom from PWD was higher in patients without major adverse cardiac and cerebrovascular event (MACCE) (at 5 years, 85.6 vs. 71.9%, P < 0.001). Nevertheless, rate of PWD was high also in patients without MACCE and patients with preserved ejection fraction during follow-up. Conclusions: Although coronary revascularization confers good overall survival in young patients, PWD is common especially after CABG and mostly for cardiac reasons even without occurrence of MACCE. Supportive measures to preserve occupational health are warranted concomitantly with coronary revascularization at all levels of health care. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  CABG; Coronary artery disease; Disability; PCI; Pension; Young

Mesh:

Year:  2017        PMID: 28927176     DOI: 10.1093/ehjqcco/qcw043

Source DB:  PubMed          Journal:  Eur Heart J Qual Care Clin Outcomes        ISSN: 2058-1742


  5 in total

1.  Interventions to support return to work for people with coronary heart disease.

Authors:  Janice Hegewald; Uta E Wegewitz; Ulrike Euler; Jaap L van Dijk; Jenny Adams; Alba Fishta; Philipp Heinrich; Andreas Seidler
Journal:  Cochrane Database Syst Rev       Date:  2019-03-14

2.  Trends in Diagnosis-Specific Work Disability Before and After Stroke: A Longitudinal Population-Based Study in Sweden.

Authors:  Tea Lallukka; Jenni Ervasti; Erik Lundström; Ellenor Mittendorfer-Rutz; Emilie Friberg; Marianna Virtanen; Kristina Alexanderson
Journal:  J Am Heart Assoc       Date:  2018-01-04       Impact factor: 5.501

3.  Trends in diagnosis-specific work disability before and after ischaemic heart disease: a nationwide population-based cohort study in Sweden.

Authors:  Jenni Ervasti; Marianna Virtanen; Tea Lallukka; Emilie Friberg; Ellenor Mittendorfer-Rutz; Erik Lundström; Kristina Alexanderson
Journal:  BMJ Open       Date:  2018-04-19       Impact factor: 2.692

4.  Effect of nursing intervention based on Maslow's hierarchy of needs in patients with coronary heart disease interventional surgery.

Authors:  Ji-Xue Xu; Lin-Xue Wu; Wei Jiang; Gui-Hong Fan
Journal:  World J Clin Cases       Date:  2021-11-26       Impact factor: 1.337

5.  Permanent work disability before and after ischaemic heart disease or stroke event: a nationwide population-based cohort study in Sweden.

Authors:  Jenni Ervasti; Marianna Virtanen; Tea Lallukka; Emilie Friberg; Ellenor Mittendorfer-Rutz; Erik Lundström; Kristina Alexanderson
Journal:  BMJ Open       Date:  2017-09-29       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.